Aspire Biopharma Holdings (ASBP) Asset Utilization Ratio (2026)
Aspire Biopharma Holdings' (ASBP) quarterly Asset Utilization Ratio came in at 0.01 in Q2 2026.
Powered by 
Analysis
Aspire Biopharma Holdings (ASBP) Asset Utilization Ratio (2026) Analysis & Trends
Aspire Biopharma Holdings (ASBP) has reported Asset Utilization Ratio for 1 consecutive years, with 0.01 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Asset Utilization Ratio changed N/A year-over-year to 0.01 in Q2 2026; TTM through Jun 2026 was 0.01, a N/A change from a year earlier, with the FY2025 full-year figure at 0.01, changed N/A from the prior year.
- Asset Utilization Ratio was 0.01 for Q2 2026 at Aspire Biopharma Holdings.
- Over five years, Asset Utilization Ratio peaked at 0.01 in Q2 2026 and troughed at 0.01 in Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | 0.40 |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | 0.58 |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | 0.47 |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | 0.38 |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | 0.20 |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | - |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | 0.90 |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | 0.33 |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | 0.00 |
| 10 | Aspire Biopharma Holdings | 64.13 Mn | 51.96 Mn | -30,086.00 | 0.01 |